Management of major bleeding outcomes under antithrombotic therapy in real-life
- PMID: 31951935
- DOI: 10.1016/j.thromres.2020.01.007
Management of major bleeding outcomes under antithrombotic therapy in real-life
Conflict of interest statement
Declaration of competing interest Dr. Moustafa has served as a consultant for Bayer HealthCare Pharmaceuticals, Boehringer Ingelheim and Sanofi, been a speaker for Bayer HealthCare Pharmaceuticals, Boehringer Ingelheim, Daiichi-Sankyo and Sanofi, and received grants from Sanofi, Bayer HealthCare, Roche diagnosis and LFB. Dr. Schmidt has received payments for board membership from Bayer, Daichi, Lilly, and Pfizer, as well as personal compensation from Biomerieux, Bohringer Ingelheim, Sanofi, and Novartis. All other authors have reported that they have no conflicts of interest relevant to the contents of this paper to disclose.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
